Matthew Jackson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 161 Falmouth Rd, Mashpee, MA 02649 Phone: 508-477-2490 |
Diane Louise Kraus Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 30 Park Place Way, Mashpee, MA 02649 Phone: 774-521-4199 |
Consistent Care Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Captains Row, Mashpee, MA 02649 Phone: 508-367-2539 |
Isabela D Avelar Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 161 Falmouth Rd, Mashpee, MA 02649 Phone: 508-403-6137 |
Julia A Petricca, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 161 Falmouth Rd, Mashpee, MA 02649 Phone: 508-477-2490 |
Alexandra Corsi Occupational Therapist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 34 Sandy Way, Mashpee, MA 02649 Phone: 508-681-9120 |
Casey Nicole Van Huysen, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Birch Way, Mashpee, MA 02649 Phone: 251-554-6334 |
Miss Laura Lemelin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 161 Falmouth Rd, Mashpee, MA 02649 Phone: 508-477-2490 |
Jennifer L Griffin Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 462 Old Barnstable Rd, Mashpee, MA 02649 Phone: 508-418-0302 |
News Archive
Some of the nation's rising music stars have joined the nation's first cancer center in an effort to show young people that they can help build a world without cancer. Roswell Park Cancer Institute created a new hip hop song and video called "How Big Is Your Heart." The MTV-like commercial features cancer patients and nurses dancing alongside professional dancers through the halls and lobby of the cancer hospital.
The authors base their findings on an analysis of the anonymised search logs of millions of US web users, who agreed to install a browser add-on and share their online searches with Microsoft throughout 2010.
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
A retrospective review of 633 adults and children who underwent bioprosthetic pulmonary valve replacement (PVR) for congenital heart disease between 1996 and 2014 indicated that the risk of re-intervention was five times greater for children than adults, with the likelihood of re-intervention decreasing by 10% for each increasing year of age at surgery.
› Verified 3 days ago